Company / SG&A Expense
Ceribell, Inc. SG&A Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$44.5M
FY2025
5-year range
$20.3M / $44.5M
FY2023-FY2025
Trend
+119.1%
vs FY2024
Sector context
#147 of 158
Health Care
What the data says
Among 158 Health Care companies, Ceribell, Inc. is in the top 7% for sg&a expense. Increased from $20M to $44M over the past 2 years.
Based on SEC 10-K filings.
$44M in FY2025.
Increased from $20M to $44M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 158This company $44.5M Sector average $175.9B
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a expense increased 119.1% year-over-year.
- Ranks #147 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $44.5M | +119.1% |
| FY2024 | $20.3M | +0.0% |
| FY2023 | $20.3M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026